Investigation Overview
An investigation on behalf of investors in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock over possible violations of Federal Securities Laws by Arena Pharmaceuticals and others in connection with the rejection of the lorcaserin New Drug Application by the US Food and Drug Administration. Arena Pharmaceuticals, Inc., located in San Diego, California, is a clinical-stage biopharmaceu...
You must register (for free) or login to view the entire investigation.